Neuvivo
Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS. NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
9
organic / mo
Sign up free to see all 6 verified contacts at Neuvivo
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- YL
Yuval Luria
Chief of Staff · Operations
EmailPhone - AA
Ari Azhir
Chief Executive Officer · Other
EmailPhone - NH
Nancy Haire
Avalyn Pharma · Other
EmailPhone
Showing 3 of 6 verified contacts
Top roles at Neuvivo
5 distinct titles indexed · top 5 shown.
- 1ampio pharmaceuticals inc (ampe)
- 1avalyn pharma
- 1chief executive officer
- 1chief of staff
- 1head of communications
Sign up to unlock all 6 contacts at Neuvivo
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Neuvivo
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.